Tatsuyoshi Hirano

UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It operates through a following business division: Next-generation biopharmaceutical in-house development business and Biopharmaceutical contract manufacturing business. The Next-generation biopharmaceutical in-house development business engages in the research and development of next-generation logical vaccine by integrating next-generation biopharmaceutical drug substance manufacturing technology, adjuvant technology and drug delivery technology. The Biopharmaceutical contract manufacturing business offers study samples, investigational drugs, products, and various evaluation test results. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan.

Toys "R" Us-Japan Ltd. operates a chain of toy and juvenile products retail stores. Its products include educational toys, dolls, plush toys and character toys, video games, bicycles, sporting goods, stationery, baby clothing, shoes, strollers, car seats, food and formula. The company was founded on November 21, 1989 and is headquartered in Kawasaki, Japan.

UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan.